GenoKey establish UK subsidiary

April 04, 2013

Apr 4 2013, GenoKey announces first overseas expansion into booming UK biotech and healthcare hub around Cambridge.

Danish big data analytics company GenoKey is pleased to announce that it has established its first overseas subsidiary at Copley Hill near Babraham Research Park, Cambridge. The subsidiary will be led by Dr Steve Gardner and Henrik Kristiansen.

“We are working with a number of major UK partners to develop scalable data analysis solutions that will be crucial to the delivery of next-generation healthcare. Our new Cambridge, UK office will give us access to world-leading R&D at Cambridge’s world-ranking university, as well as our collaborators on Addenbrooke’s research campus and in the local high-tech biopharma and service companies,” says Henrik Kristiansen, CEO and co-founder, GenoKey.

About GenoKey: GenoKey was established in 2010 with the aim of helping to equip pharmaceutical and healthcare companies with the tools and knowledge needed to transform the provision of healthcare for millions of patients worldwide. GenoKey’s array-based logic approach was designed to allow massive multi-factorial data analysis and enable complex clinical decision making to be performed at the point of care on mobile devices. Its technology has been proven extensively in safety critical industries from the nuclear and railroad industries to electronics and configuration management.

Comments are closed.